e-learning
resources
Vienna 2003
Monday 29.09.2003
Effect of smoking on COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinic significance of exhaled CO determined in a smoking medical setting
J. J. Garrido, F. L. Marquez, L. Mateos, M. J. Antona, I. Rodriguez, A. M. Perez, F. Fuentes (Badajoz, Spain)
Source:
Annual Congress 2003 - Effect of smoking on COPD
Session:
Effect of smoking on COPD
Session type:
Thematic Poster Session
Number:
1951
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. J. Garrido, F. L. Marquez, L. Mateos, M. J. Antona, I. Rodriguez, A. M. Perez, F. Fuentes (Badajoz, Spain). Clinic significance of exhaled CO determined in a smoking medical setting. Eur Respir J 2003; 22: Suppl. 45, 1951
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Exhaled carbon monoxide and degree of dependency in smokers attending an antismoking center
Source: Annual Congress 2007 - Smoking cessation
Year: 2007
Measurement of urinary cotinine and exhaled air carbon monoxide levels among active, passive smoker and non-smoker health staff
Source: Eur Respir J 2006; 28: Suppl. 50, 470s
Year: 2006
Optimal cut-off point of exhaled carbon monoxide to validate self-reported smoking status in healthy adults
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Cut-off levels for exhaled carbon monoxide in smoking cessation program
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006
Smoking status in patiets with COPD and Asthma: A comparison of self-reported behavior with exhaled carbon monoxide
Source: Eur Respir J 2002; 20: Suppl. 38, 577s
Year: 2002
COPD: Exhaled NO concentration and its prognostic value for smoking patient
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Dynamics of exhaled breath temperature (EBT) after a smoked cigarette
Source: International Congress 2016 – New approaches and finding in smoking cessation
Year: 2016
Measurement of exhaled breath temperature in science and clinical practice
Source: Breathe 2012; 8: 186-192
Year: 2012
NO and CO: overview of their diagnostic potential in the critically ill patient
Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice
Year: 2005
The exhaled carbon monoxide levels, respiratory function tests and the blood oxidative stress levels of the petrol station workers
Source: International Congress 2015 – Occupational and environmental exposure assessment and biomarkers
Year: 2015
Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006
The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
The dynamics of free radical parameters in exhaled breath condensate (EBC) in smokers during the course of physical workload
Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation
Year: 2011
The level of exhaled NO in the epidemiology study
Source: Annual Congress 2008 - Early life risk factors for childhood asthma: evidence from birth cohort studies II
Year: 2008
Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma
Source: Eur Respir J 2007; 30: 545-548
Year: 2007
Personalised exhaled nitric oxygen fraction (
F
ENO
)-driven asthma management in primary care: a
F
ENO
subgroup analysis of the ACCURATE trial
Source: ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019
Year: 2020
Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled breath temperature as a possible early marker in smokers at risk for COPD (MARKO study)
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept